Peptide questions · KPV
KPV side effects: what studies and users report
Reviewed Evidence: EmergingPublished by PepVault
The library lists two common side effects for KPV, injection site irritation and mild nausea, and a safety note; its research is mostly in animals and cells, so reports in people come from community use.
Its safety note opens: KPV is the C-terminal tripeptide of alpha-MSH.
What is commonly reported with KPV
- Injection site irritation
- Mild nausea
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 18) |
|---|---|
| Injection site irritation | 1: BPC-157 |
| Mild nausea | None: listed for KPV alone |

Which KPV side effects the healing & recovery group shares
Across the 19 healing & recovery compounds in the library, the effects listed most often are headache (7 of 19), injection site reaction (7 of 19), nausea (rare) (7 of 19) and fatigue (6 of 19). KPV shares 1 of its 2 listed effects with at least one other healing & recovery compound; mild nausea is listed for KPV alone.
What the KPV safety notes say
The library’s safety note
KPV is the C-terminal tripeptide of alpha-MSH. It lacks the sequence melanocortin receptors bind and acts on the NF-kB pathway inside cells instead, so it does not stimulate pigmentation. Its preclinical studies (mouse colitis and skin-inflammation models) weren't designed to test safety, no toxicity study of KPV has been published, and zero published human safety data exists for KPV by any route. Community use reports it as well tolerated with occasional mild injection-site reactions. Treat the safety picture as preclinical-only and discuss with your clinician.
The library’s interaction note
No published human interaction data exists for KPV with SSRIs, anticoagulants, insulin/antidiabetics, or thyroid medication. Its anti-inflammatory mechanism (cytokine/NF-kB modulation) has no established clinical interaction with these classes. In gut-focused stacks it is commonly combined with BPC-157; no combination-specific interaction studies exist. Discuss your medications with your clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the KPV reports come from
The library rates the evidence on KPV as emerging: mostly preclinical, with limited human data.
Of the library’s 6 research notes on KPV, 4 rest on animal studies and 2 on community reports.
Our 3 study pages on KPV: 3 animal studies (mice).
So the effects listed for KPV come from people who have used it, not from a controlled trial in people.
Questions people ask
What are the side effects of KPV?
The library lists two common side effects for KPV, injection site irritation and mild nausea, and a safety note; its research is mostly in animals and cells, so reports in people come from community use.
Do KPV’s side effects come from human studies?
The library rates the evidence on KPV as emerging, and its research is mostly in animals and cells, so reports in people come from community use.
Which KPV side effects are its own?
Among the healing & recovery compounds, the library lists mild nausea for KPV alone.
Does KPV interact with other medicines?
The library’s interaction note on KPV begins: No published human interaction data exists for KPV with SSRIs, anticoagulants, insulin/antidiabetics, or thyroid medication.